ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1385	National Cancer Institute	Html	en	Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing ovarian, fallopian tube, and primary peritoneal cancers and about research aimed at the prevention of them.	oral contraceptives 0.660699 untreated subfertile women 0.554695 population-based case-control study 0.569591 multiple case-control studies 0.577558 tubal ligation 0.612813 ovarian cancer subtypes 0.638647 endometrioid carcinomas 0.557685 Ovarian Cancer Association 0.647707 invasive ovarian tumors 0.625952 tubal intraepithelial carcinoma 0.613375 case-control studies 0.724549 modest increased risk 0.571056 ovarian cancer 0.933826 clear cell carcinomas 0.577194 oral contraceptive therapy 0.556361 ovarian carcinoma 0.65109 ovarian reserve 0.599754 ovarian borderline tumor 0.646023 low-grade ovarian carcinomas. 0.649208 ovarian primary tumors. 0.639278 high-grade carcinomas 0.568553 cohort studies 0.697042 hospital-based case-control studies 0.582441 ovarian cancer cases 0.640486	epithelial ovarian cancers 0.62928 women 0.680224 borderline ovarian tumors 0.627194 prospective cohort studies 0.573074 risk reduction 0.631051 cohort study 0.558817 ovarian carcinomas 0.707015 clear cell cancer 0.56063 ovarian cancers 0.642329 unexposed infertile women 0.555673 observed risk reduction 0.618238 ovarian hyperstimulation 0.617463 significant increased risk 0.567639 high-grade serous carcinomas 0.73533 fallopian tube 0.554218 epithelial ovarian cancer 0.644523 ovarian cancer risk 0.740549 epidemiological studies 0.565 population-based case-control studies 0.621559 gastrointestinal primary tumors 0.557125 Netherlands cohort study 0.55691 ovarian carcinoma subtypes 0.642907 meta-analysis 0.563338 systematic review 0.583056	CLICK HERE
1387	National Cancer Institute	Html	en	Breast Cancer Prevention (PDQ®)–Health Professional Version	Risk factors for breast cancer are female sex and advancing age, inherited risk, breast density, obesity, alcohol consumption, and exposure to ionizing radiation. Interventions to prevent breast cancer include chemoprevention (e.g. SERMs, AIs), risk-reducing surgery (e.g. mastectomy, oophorectomy). Review the evidence on risk factors and interventions to prevent breast cancer in this expert-reviewed summary.	Surgical Adjuvant Breast 0.484835 situ breast cancer 0.497037 Breast Cancer Intervention 0.493501 breast cancer trends 0.484079 breast cancer deaths 0.490132 radiation-associated breast cancer 0.489257 Engl J Med 0.493511 post-menopausal breast cancer 0.480461 Breast Cancer Surveillance 0.4815 breast cancer incidence. 0.495634 treatment-related breast cancer 0.489379 early-stage breast cancer 0.507669 fatal breast cancer 0.490061 ER-positive breast cancer 0.490928 breast cancer prevention 0.509672 Breast Cancer Collaborative 0.483305 breast cancer patients 0.502781 postmenopausal breast cancer 0.486608 therapy-related breast cancer 0.480826 breast cancer risk. 0.512722 Natl Cancer Inst 0.684414 -negative breast cancer 0.484014 breast cancer death 0.482095 invasive breast cancer 0.614612 et al. 0.488773	Swedish breast cancer 0.480364 women 0.553885 contralateral breast cancer 0.510667 early breast cancer 0.491581 age-specific breast cancer 0.483209 breast cancer susceptibility 0.482582 breast cancers 0.487583 age-adjusted breast cancer 0.485699 breast cancer rates 0.491912 human breast cancer 0.484504 tamoxifen breast cancer 0.487689 Female Breast Cancer 0.482581 postmenopausal women 0.549947 breast cancer risk 0.650399 International Breast Cancer 0.494317 Abstract 0.524687 breast cancer 0.96573 breast cancer mortality 0.521549 breast cancer cases 0.492675 Breast Cancer Study 0.481834 ER-negative breast cancer 0.487382 breast cancer incidence 0.616078 elevated breast cancer 0.489604 Excess breast cancer 0.489271	CLICK HERE
1412	National Cancer Institute	Html	en	Lung Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.	skin cancer 0.349544 cancer treatment 0.344722 cancer prevention trials 0.366779 lung cancer screening 0.424963 lung cancer prevention 0.444623 prevention clinical trials 0.358195 protective factors 0.365293 following PDQ summaries 0.35677 PDQ cancer information 0.428189 lung cancer 0.930545 clinical trials 0.420475 secondhand smoke 0.364049 important risk factor 0.350351 cancer information summary 0.398033 small cell lung 0.428578 left lung 0.393411 breast cancer prevention 0.35675 cancer patients 0.344267 cancer risk factor 0.388012 low-dose spiral ct 0.356728 NCI PDQ cancer 0.3773 radiation therapy 0.36772 new cases 0.35557 CT scans 0.355102	cancer risk factors 0.383293 cancer protective factor 0.369464 smokers 0.342644 Atomic bomb radiation 0.359839 Cancer Information Service 0.361682 spiral CT scans 0.353441 common cancer 0.34956 smoking 0.374366 Prevention Editorial Board 0.360434 lower their risk 0.346462 National Cancer Institute 0.402346 new lung cancers 0.398324 smoking low tar 0.343862 Cancer Care page 0.356844 right lung 0.388076 non-small cell lung 0.429832 people 0.358421 PDQ summary 0.34571 cancer -causing agents 0.363798 cancer clinical trials 0.36639 cell lung cancer 0.479294 risk factors 0.409463 cancer information summaries 0.364825 comprehensive cancer information 0.364576	CLICK HERE
1698	National Cancer Institute	Html	en	Topics in Integrative, Alternative, and Complementary Therapies (PDQ®)–Patient Version	Expert-reviewed information summary that contains information on integrative, complementary, and/or alternative therapies for people with cancer.	treatment 0.496567 cancer treatment 0.492995 cancer prevention 0.491725 Complementary Therapies Editorial 0.451339 Cancer Information Specialist 0.463468 cancer cells 0.485902 section 0.463945 Cancer Information Service 0.487907 Herbs/Dietary Supplements section 0.454711 Cancer Complementary 0.464741 breast cancer section 0.455211 CAM therapies 0.453618 specific PDQ summary 0.507776 dietary supplements 0.518422 National Cancer Institute 0.533776 studies 0.454937 clinical trials 0.547318 cancer information summary 0.522295 alternative medicine 0.513784 PDQ documents 0.462433 alternative cancer therapies 0.45948 clinical trial 0.455001 prostate cancer cells 0.455068 CAM cancer research 0.449455	PDQ health 0.555354 PDQ summaries 0.468855 cancer patients 0.523763 PDQ database 0.46397 PDQ Topics 0.462207 fight cancer 0.449901 breast cancer 0.455561 prostate cancer patients 0.471774 NCI’s PDQ 0.468435 PDQ summary 0.513781 professional summary 0.498282 body fight cancer 0.448775 NCI PDQ cancer 0.502954 cancer information database 0.46436 prostate cancer 0.542459 complementary therapies 0.470524 alternative therapies 0.455648 hot flashes 0.501425 cancer information summaries 0.489288 cancer 0.694704 information 0.593851 PDQ Integrative 0.464074 PDQ patient summary 0.974252	CLICK HERE
1840	National Cancer Institute	Html	es	Tratamiento de la enfermedad trofoblástica de la gestación (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la enfermedad trofoblástica de la gestación.	Obstet Gynecol 0.314049 calificación pronóstica 0.330592 Agarwal R 0.309981 gestational trophoblastic tumor 0.470216 gynecologic oncology 0.31949 gestational trophoblastic tumour 0.330225 Sin embargo 0.495025 largo plazo 0.308011 drug-resistant gestational trophoblastic 0.316646 trophoblastic tumor simulating 0.31025 gestational trophoblastic 0.969098 high-risk gestational trophoblastic 0.417868 site trophoblastic tumor 0.331006 Epithelioid trophoblastic tumor 0.331525 oncology group study 0.309029 retrospective observational study 0.310708 trophoblastic neoplasia with 0.311489 trophoblastic tumor 0.525373 newlands es 0.321142 gestational trophoblastic neoplasia 0.524164 Gynecol Oncol 0.321149 Database Syst Rev 0.308864 placental site trophoblastic 0.326491 chemorefractory gestational trophoblastic 0.316598 Reprod Med 0.395131	gynecologic oncology group 0.309183 Lancet Oncol 0.308542 Organización Mundial 0.310432 tumores trofoblásticos epitelioides 0.326002 Lurain JR 0.332449 metastatic gestational trophoblastic 0.30963 Holden L 0.308229 Cancer Staging Manual 0.311272 Féderation Internationale 0.320433 trophoblastic disease 0.450228 with gestational trophoblastic 0.311191 trophoblastic tumours 0.335737 Recurrent gestational trophoblastic 0.309132 Clin Oncol 0.324887 sistema nervioso central 0.319546 low-risk gestational trophoblastic 0.340233 Charing Cross 0.316962 Gynaecol Obstet 0.314146 persistent gestational trophoblastic 0.309878 Short D 0.308931 FIGO Committee 0.309443 Charing Cross Hospital 0.309844 Obstet Gynaecol 0.310271 AJCC Cancer Staging 0.31188	CLICK HERE
1857	National Cancer Institute	Html	es	Tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto.	ominosa situación 0.323583 microscopic findings with 0.340934 poorly differentiated tumors 0.343157 cisplatin-based combination chemotherapy 0.340177 unknown primary site 0.370765 N)a aReproducción 0.321827 Instituto Nacional 0.378061 Radiat Oncol Biol 0.947729 bUna designación 0.320629 emission tomography with 0.337851 Diagn Pathol 0.32218 chemoradiotherapy using 0.320607 solid tumors 0.321716 Acta Cytol 0.320567 Head Neck Surg 0.377028 primary site 0.383303 after excisional biopsy 0.335976 metastases from 0.417556 dysfunction following radiotherapy 0.335828 carcinoma nasofaríngeo 0.419271 Kahn HJ 0.320427 paciente varón 0.325653 cervical lymph 0.356026 Recent progress 0.321743 intensity-modulated radiotherapy 0.356033	Cheung R 0.361917 from unknown primary 0.367172 National Cancer Institute 0.343401 PDQ Tratamiento 0.380147 nasopharyngeal carcinoma 0.428219 Lombardi Comprehensive Cancer 0.345987 Clin Oncol 0.335468 unknown primary 0.700357 Physician Data Query 0.330819 enfermedad n2 0.320558 Oncol Biol Phys 0.999042 enfermedad n1 0.322779 largo plazos 0.351849 metastatic adenocarcinomas 0.360803 unknown primary tumor 0.440765 Induction chemotherapy with 0.342645 Gray GF Jr 0.331989 neck cancer 0.546903 American Joint Committee 0.331644 Reimann BE 0.320391 Miyazaki I 0.364645 AJCC Cancer Staging 0.353491 squamous cell carcinoma 0.742589 solitary metastatic neck 0.365007	CLICK HERE
1973	National Cancer Institute	Html	es	Tratamiento del cáncer de glándulas salivales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de glándulas salivales.	Neck Cancer 0.247421 siguientes procedimientos 0.717657 siguientes aspectos 0.315855 estadio ii 0.901856 vía oral 0.251714 rayos x 0.574567 pequeñas marcas 0.24571 enlace drugs approved 0.287895 exploración tac 0.270837 National Cancer Institute 0.238285 siguientes riesgos 0.235555 Instituto Nacional 0.352284 malla ayuda 0.248945	PDQ Tratamiento 0.283565 partículas minúsculas 0.2536 radioterapia envía neutrones 0.431263 presente sección 0.245937 explorador tep 0.281651 Physician Data Query 0.352077 estadio iii 0.736431 principales cánceres 0.411638 siguientes situaciones 0.301582 ganglio linfático mide 0.91402 cáncer.ampliar radioterapia 0.391316 siguientes enlaces 0.247009 siguientes pruebas 0.31121	CLICK HERE
3652	National Cancer Institute	Html	es	Cannabis y canabinoides (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso del Cannabis y canabinoides para el tratamiento de los efectos secundarios relacionados con el tratamiento del cáncer, como la náusea y el vómito.	Natl Acad Sci 0.394203 cannabinoid receptor cb2 0.362796 Neck Cancer Epidemiology 0.340717 with peripheral cb1 0.353749 accessed october 0.451422 receptores cb2 0.414613 Sin embargo 0.375752 receptores cb1 0.617059 Mol Cancer Ther 0.460254 cb2 receptors 0.369543 marijuana as 0.341164 potencial receptor 0.334026 cannabinoid cb1 0.353877 Nat Rev Cancer 0.38837 receptor cb2 0.381409 receptor cb1 0.494644 endogenous cannabinoid 0.347836 Cancer Res 0.471447 Pharmacol Biochem Behav 0.366013 Marihuana Tax Act 0.373003 cannabinoid receptor activation 0.352792 lesiones premalignas 0.350108 cannabinoid receptor with 0.35689 Estados Unidos 0.902915 endogenous cannabinoid system 0.33287	Pain Symptom Manage 0.358772 endocannabinoid system as 0.404957 Integrating cannabis 0.433732 Pharmacol Rev 0.370877 Targeting CB2 cannabinoid 0.338858 ancient cannabis from 0.417929 Cannabidiol inhibits 0.365208 Proc Natl Acad 0.396634 canabinoides endógenos 0.435834 cannabinoid receptor 0.890303 CB2 receptor agonists 0.350942 cannabis sativa l 0.444025 Blázquez C 0.343327 chemokine receptor cxcr4 0.338077 Cannabis sativa extract 0.416057 cell proliferation 0.33314 sistema nervioso central 0.343143 breast cancer 0.515229 Cannabis medicinal 0.719247 receptores canabinoides 0.400314 emerging target 0.333482 Cannabis versus 0.409865 agonistas canabinoides 0.344588 CB2 cannabinoid 0.361915	CLICK HERE
3879	National Cancer Institute	Html	es	Extractos de muérdago (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de los extractos de muérdago como tratamiento para personas con cáncer.	cuerpo frente 0.413451 Centro Nacional 0.449381 New Hampshire Avenue 0.415853 cabo ensayos 0.424385 Drug Administration 0.409825 NCI Best Case 0.428572 PDQ Extractos 0.439937 Helixor A 0.41291 datos bibliográficos pubmed 0.416761 marcas comerciales eurixor 0.426376 siguientes preguntas 0.410006 productos botánicos 0.410905 Polyerga Neu 0.415135 solicitudes ind 0.41359 cura lotodo 0.415539 vitamina b 0.413657 siguientes riesgos 0.412404 Instituto Nacional 0.532861 National Center 0.412812	siguientes marcas 0.416399 Salud Complementaria 0.466538 idioma alemán 0.413696 Visuals Online 0.41151 complementarias revisa 0.415619 Physician Data Query 0.465832 Estados Unidos 0.692378 mejores cuidados 0.41274 libre uso 0.41183 cabo estudios 0.418615 Integrative Health 0.413952 página manejo 0.410784 ¿El tratamiento 0.420943 ¿Los beneficios 0.40989 juntos cam 0.409184 respuesta corporal frente 0.42523 Series Program 0.409771 medicina complementaria 0.946895 árbol hospedador 0.450028	CLICK HERE
3899	National Cancer Institute	Html	en	National Cancer Act of 1937	National Cancer Act of 1937, signed into law by President Franklin D. Roosevelt, created the National Cancer Institute.	general public 0.367365 National Cancer Advisory 0.528357 cancer control work 0.436895 research projects 0.391515 act 0.566247 similar research 0.476584 General its approval 0.365736 federal government 0.49191 Cancer Institute Act 0.442221 appointed member 0.370413 National Advisory Cancer 0.52537 technical matters 0.410467 prevention 0.411559 human knowledge 0.397925 diagnosis 0.527183 non-communicable disease 0.363394 Cancer Advisory Council 0.437071 PUBLIC NO. 0.367229 independent research institute 0.437264 principal agency 0.418501 similar research activities 0.412381 treatment centers 0.373224 National Cancer Act 0.475787 treatment 0.554492 valuable contributions 0.393688	United States 0.637137 methods 0.412995 Institute consultation services 0.410647 cause 0.426942 training 0.369834 Advisory Cancer Council 0.524827 cancer research 0.428314 private institutions 0.416999 Franklin D. Roosevelt 0.416988 Public Law 0.367866 cancer experts 0.38424 State health agencies 0.402781 National Cancer Institute 0.913007 official business 0.397421 research institutions 0.36768 Committee Report No. 0.406179 approval 0.369507 HR.7931. 75th Congress 0.4075 acceptance conditional gifts 0.395258 Cancer Investigations 0.395678 Surgeon General 0.940401 Public Health Service 0.694963 75th congress 0.416285 time 0.374442	CLICK HERE